112 related articles for article (PubMed ID: 25022024)
1. New collaboration aims to aid target validation and drive drug discovery.
Wilson H
Pharmacogenomics; 2014 Apr; 15(6):732. PubMed ID: 25022024
[No Abstract] [Full Text] [Related]
2. The role of public-private partnerships in addressing the biomedical innovation challenge.
Said M; Zerhouni E
Nat Rev Drug Discov; 2014 Nov; 13(11):789-90. PubMed ID: 25359362
[TBL] [Abstract][Full Text] [Related]
3. Competition: Unlikely partnerships.
Savage N
Nature; 2016 May; 533(7602):S56-8. PubMed ID: 27167391
[No Abstract] [Full Text] [Related]
4. Public-private partnerships to revitalize psychiatric drug discovery.
Brady LS; Potter WZ
Expert Opin Drug Discov; 2014 Jan; 9(1):1-8. PubMed ID: 24308355
[TBL] [Abstract][Full Text] [Related]
5. Re-engineering drug discovery and development.
FitzGerald GA
LDI Issue Brief; 2011 Oct; 17(2):1-4. PubMed ID: 22049582
[TBL] [Abstract][Full Text] [Related]
6. New frontiers for collaborative research.
Goldman M
Sci Transl Med; 2013 Dec; 5(216):216ed22. PubMed ID: 24353157
[No Abstract] [Full Text] [Related]
7. The role of product development partnerships in advancing the development of drugs for unmet needs.
Breitstein J; Spigelman M
Clin Pharmacol Ther; 2013 Jun; 93(6):468-70. PubMed ID: 23689211
[No Abstract] [Full Text] [Related]
8. Universities shun Europe's drug initiative.
Gilbert N
Nature; 2010 Jul; 466(7304):306-7. PubMed ID: 20631770
[No Abstract] [Full Text] [Related]
9. Informatics for neglected diseases collaborations.
Bost F; Jacobs RT; Kowalczyk P
Curr Opin Drug Discov Devel; 2010 May; 13(3):286-96. PubMed ID: 20443162
[TBL] [Abstract][Full Text] [Related]
10. Four disruptive strategies for removing drug discovery bottlenecks.
Ekins S; Waller CL; Bradley MP; Clark AM; Williams AJ
Drug Discov Today; 2013 Mar; 18(5-6):265-71. PubMed ID: 23098820
[TBL] [Abstract][Full Text] [Related]
11. The innovative medicines initiative: a European response to the innovation challenge.
Goldman M
Clin Pharmacol Ther; 2012 Mar; 91(3):418-25. PubMed ID: 22318619
[TBL] [Abstract][Full Text] [Related]
12. Traditional drug-discovery model ripe for reform.
Cressey D
Nature; 2011 Mar; 471(7336):17-8. PubMed ID: 21368796
[No Abstract] [Full Text] [Related]
13. Leveraging crowdsourcing to facilitate the discovery of new medicines.
Norman TC; Bountra C; Edwards AM; Yamamoto KR; Friend SH
Sci Transl Med; 2011 Jun; 3(88):88mr1. PubMed ID: 21697527
[TBL] [Abstract][Full Text] [Related]
14. A collaborative pipeline.
Nat Neurosci; 2015 Jan; 18(1):1. PubMed ID: 25547471
[No Abstract] [Full Text] [Related]
15. Cooperative development of antimicrobials: looking back to look ahead.
Nathan C
Nat Rev Microbiol; 2015 Oct; 13(10):651-7. PubMed ID: 26373373
[TBL] [Abstract][Full Text] [Related]
16. Promoting drug discovery by collaborative innovation: a novel risk- and reward-sharing partnership between the German Cancer Research Center and Bayer HealthCare.
Wellenreuther R; Keppler D; Mumberg D; Ziegelbauer K; Lessl M
Drug Discov Today; 2012 Nov; 17(21-22):1242-8. PubMed ID: 22521665
[TBL] [Abstract][Full Text] [Related]
17. Overcoming the current deadlock in antibiotic research.
Schäberle TF; Hack IM
Trends Microbiol; 2014 Apr; 22(4):165-7. PubMed ID: 24698433
[TBL] [Abstract][Full Text] [Related]
18. Open-access public-private partnerships to enable drug discovery--new approaches.
Müller S; Weigelt J
IDrugs; 2010 Mar; 13(3):175-80. PubMed ID: 20191434
[TBL] [Abstract][Full Text] [Related]
19. When fragments link: a bibliometric perspective on the development of fragment-based drug discovery.
Romasanta AKS; van der Sijde P; Hellsten I; Hubbard RE; Keseru GM; van Muijlwijk-Koezen J; de Esch IJP
Drug Discov Today; 2018 Sep; 23(9):1596-1609. PubMed ID: 29738823
[TBL] [Abstract][Full Text] [Related]
20. Public-private collaborations and partnerships in stratified medicine: making sense of new interactions.
Chataway J; Fry C; Marjanovic S; Yaqub O
N Biotechnol; 2012 Sep; 29(6):732-40. PubMed ID: 22446473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
